nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—Dofetilide—Rosiglitazone—type 2 diabetes mellitus	0.372	1	CrCrCtD
Dronedarone—ADRA2A—type 2 diabetes mellitus	0.0964	0.537	CbGaD
Dronedarone—CYP3A4—type 2 diabetes mellitus	0.0443	0.247	CbGaD
Dronedarone—ALB—type 2 diabetes mellitus	0.0387	0.216	CbGaD
Dronedarone—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0196	0.0744	CbGbCtD
Dronedarone—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0178	0.0676	CbGbCtD
Dronedarone—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0169	0.0641	CbGbCtD
Dronedarone—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0154	0.0582	CbGbCtD
Dronedarone—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0143	0.0542	CbGbCtD
Dronedarone—ALB—Gliclazide—type 2 diabetes mellitus	0.0136	0.0515	CbGbCtD
Dronedarone—ALB—Repaglinide—type 2 diabetes mellitus	0.0128	0.0484	CbGbCtD
Dronedarone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0446	CbGbCtD
Dronedarone—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0113	0.0428	CbGbCtD
Dronedarone—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0107	0.0404	CbGbCtD
Dronedarone—ALB—Valsartan—type 2 diabetes mellitus	0.00941	0.0357	CbGbCtD
Dronedarone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00937	0.0356	CbGbCtD
Dronedarone—ALB—Nateglinide—type 2 diabetes mellitus	0.00875	0.0332	CbGbCtD
Dronedarone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00835	0.0317	CbGbCtD
Dronedarone—CACNA1S—pes—type 2 diabetes mellitus	0.00625	0.25	CbGeAlD
Dronedarone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00604	0.0229	CbGbCtD
Dronedarone—ALB—Glyburide—type 2 diabetes mellitus	0.00591	0.0224	CbGbCtD
Dronedarone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00569	0.0216	CbGbCtD
Dronedarone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00561	0.0213	CbGbCtD
Dronedarone—ALB—Losartan—type 2 diabetes mellitus	0.0054	0.0205	CbGbCtD
Dronedarone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00525	0.0199	CbGbCtD
Dronedarone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.005	0.019	CbGbCtD
Dronedarone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00458	0.0174	CbGbCtD
Dronedarone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00431	0.0164	CbGbCtD
Dronedarone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00415	0.0157	CbGbCtD
Dronedarone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00413	0.0157	CbGbCtD
Dronedarone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.004	0.0152	CbGbCtD
Dronedarone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00362	0.0137	CbGbCtD
Dronedarone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00309	0.0117	CbGbCtD
Dronedarone—ABCB1—Losartan—type 2 diabetes mellitus	0.00283	0.0107	CbGbCtD
Dronedarone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00274	0.0104	CbGbCtD
Dronedarone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00263	0.00997	CbGbCtD
Dronedarone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00263	0.00997	CbGbCtD
Dronedarone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00249	0.00943	CbGbCtD
Dronedarone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00185	0.00703	CbGbCtD
Dronedarone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00169	0.00643	CbGbCtD
Dronedarone—HCN4—cardiovascular system—type 2 diabetes mellitus	0.00142	0.0568	CbGeAlD
Dronedarone—CACNA1F—retina—type 2 diabetes mellitus	0.00127	0.0509	CbGeAlD
Dronedarone—HCN3—cortex of kidney—type 2 diabetes mellitus	0.00109	0.0437	CbGeAlD
Dronedarone—HCN2—cardiovascular system—type 2 diabetes mellitus	0.00108	0.043	CbGeAlD
Dronedarone—Ibutilide—KCNJ11—type 2 diabetes mellitus	0.00104	0.602	CrCbGaD
Dronedarone—HCN3—adipose tissue—type 2 diabetes mellitus	0.00101	0.0405	CbGeAlD
Dronedarone—HCN2—adipose tissue—type 2 diabetes mellitus	0.000949	0.0379	CbGeAlD
Dronedarone—HCN3—liver—type 2 diabetes mellitus	0.00071	0.0284	CbGeAlD
Dronedarone—CACNA1S—cardiovascular system—type 2 diabetes mellitus	0.000606	0.0242	CbGeAlD
Dronedarone—CACNB1—cardiovascular system—type 2 diabetes mellitus	0.000565	0.0226	CbGeAlD
Dronedarone—KCNK2—adipose tissue—type 2 diabetes mellitus	0.000554	0.0221	CbGeAlD
Dronedarone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000505	0.0202	CbGeAlD
Dronedarone—CACNB2—islet of Langerhans—type 2 diabetes mellitus	0.000504	0.0201	CbGeAlD
Dronedarone—CACNB1—adipose tissue—type 2 diabetes mellitus	0.000499	0.0199	CbGeAlD
Dronedarone—CACNB3—adipose tissue—type 2 diabetes mellitus	0.000478	0.0191	CbGeAlD
Dronedarone—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.00044	0.0176	CbGeAlD
Dronedarone—CACNB2—retina—type 2 diabetes mellitus	0.000431	0.0172	CbGeAlD
Dronedarone—CACNB2—cardiovascular system—type 2 diabetes mellitus	0.000364	0.0146	CbGeAlD
Dronedarone—Dofetilide—CYP3A4—type 2 diabetes mellitus	0.00036	0.208	CrCbGaD
Dronedarone—CACNB2—cortex of kidney—type 2 diabetes mellitus	0.000347	0.0139	CbGeAlD
Dronedarone—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.000319	0.0127	CbGeAlD
Dronedarone—ADRA1B—kidney—type 2 diabetes mellitus	0.000316	0.0126	CbGeAlD
Dronedarone—CACNA1D—pancreas—type 2 diabetes mellitus	0.00031	0.0124	CbGeAlD
Dronedarone—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.000294	0.0117	CbGeAlD
Dronedarone—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.000259	0.0104	CbGeAlD
Dronedarone—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000242	0.00968	CbGeAlD
Dronedarone—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000229	0.00917	CbGeAlD
Dronedarone—CACNB2—liver—type 2 diabetes mellitus	0.000225	0.00901	CbGeAlD
Dronedarone—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000202	0.00808	CbGeAlD
Dronedarone—Amiodarone—CYP1A2—type 2 diabetes mellitus	0.000198	0.114	CrCbGaD
Dronedarone—CACNA1D—liver—type 2 diabetes mellitus	0.000197	0.00787	CbGeAlD
Dronedarone—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000192	0.00769	CbGeAlD
Dronedarone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000191	0.00762	CbGeAlD
Dronedarone—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000181	0.00725	CbGeAlD
Dronedarone—Erythema—Glyburide—type 2 diabetes mellitus	0.000181	0.00233	CcSEcCtD
Dronedarone—Rash—Linagliptin—type 2 diabetes mellitus	0.000181	0.00233	CcSEcCtD
Dronedarone—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000181	0.00233	CcSEcCtD
Dronedarone—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000181	0.00232	CcSEcCtD
Dronedarone—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000179	0.00231	CcSEcCtD
Dronedarone—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000179	0.0023	CcSEcCtD
Dronedarone—Hepatobiliary disease—Orlistat—type 2 diabetes mellitus	0.000179	0.0023	CcSEcCtD
Dronedarone—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000179	0.0023	CcSEcCtD
Dronedarone—Vomiting—Acarbose—type 2 diabetes mellitus	0.000177	0.00228	CcSEcCtD
Dronedarone—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000176	0.00227	CcSEcCtD
Dronedarone—Rash—Acarbose—type 2 diabetes mellitus	0.000175	0.00226	CcSEcCtD
Dronedarone—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00226	CcSEcCtD
Dronedarone—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000175	0.00226	CcSEcCtD
Dronedarone—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000175	0.007	CbGeAlD
Dronedarone—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00224	CcSEcCtD
Dronedarone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000172	0.00222	CcSEcCtD
Dronedarone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000172	0.00222	CcSEcCtD
Dronedarone—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000171	0.0022	CcSEcCtD
Dronedarone—Rash—Nateglinide—type 2 diabetes mellitus	0.000169	0.00218	CcSEcCtD
Dronedarone—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000169	0.00218	CcSEcCtD
Dronedarone—ADRA2C—kidney—type 2 diabetes mellitus	0.000169	0.00676	CbGeAlD
Dronedarone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000169	0.00218	CcSEcCtD
Dronedarone—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000168	0.00217	CcSEcCtD
Dronedarone—ADRA2C—pancreas—type 2 diabetes mellitus	0.000168	0.00671	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00216	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000166	0.00214	CcSEcCtD
Dronedarone—Angioedema—Glyburide—type 2 diabetes mellitus	0.000166	0.00213	CcSEcCtD
Dronedarone—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000165	0.00213	CcSEcCtD
Dronedarone—Nausea—Acarbose—type 2 diabetes mellitus	0.000165	0.00213	CcSEcCtD
Dronedarone—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000165	0.00212	CcSEcCtD
Dronedarone—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000165	0.00658	CbGeAlD
Dronedarone—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000164	0.00212	CcSEcCtD
Dronedarone—Erythema—Gliclazide—type 2 diabetes mellitus	0.000163	0.0021	CcSEcCtD
Dronedarone—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000161	0.00208	CcSEcCtD
Dronedarone—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.00016	0.00639	CbGeAlD
Dronedarone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000159	0.00205	CcSEcCtD
Dronedarone—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000159	0.00205	CcSEcCtD
Dronedarone—Bradycardia—Metformin—type 2 diabetes mellitus	0.000159	0.00205	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000159	0.00205	CcSEcCtD
Dronedarone—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000159	0.00205	CcSEcCtD
Dronedarone—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000159	0.00204	CcSEcCtD
Dronedarone—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00204	CcSEcCtD
Dronedarone—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000158	0.00204	CcSEcCtD
Dronedarone—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000158	0.00203	CcSEcCtD
Dronedarone—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000157	0.00203	CcSEcCtD
Dronedarone—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00203	CcSEcCtD
Dronedarone—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00202	CcSEcCtD
Dronedarone—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000157	0.00202	CcSEcCtD
Dronedarone—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000156	0.00201	CcSEcCtD
Dronedarone—Pneumonia—Losartan—type 2 diabetes mellitus	0.000156	0.002	CcSEcCtD
Dronedarone—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000155	0.002	CcSEcCtD
Dronedarone—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000155	0.002	CcSEcCtD
Dronedarone—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000155	0.002	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000155	0.00199	CcSEcCtD
Dronedarone—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000155	0.00199	CcSEcCtD
Dronedarone—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000155	0.00199	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00199	CcSEcCtD
Dronedarone—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00198	CcSEcCtD
Dronedarone—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000153	0.00197	CcSEcCtD
Dronedarone—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000153	0.00197	CcSEcCtD
Dronedarone—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000152	0.00609	CbGeAlD
Dronedarone—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000152	0.00196	CcSEcCtD
Dronedarone—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00015	0.00193	CcSEcCtD
Dronedarone—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00015	0.00193	CcSEcCtD
Dronedarone—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000149	0.00191	CcSEcCtD
Dronedarone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000148	0.0019	CcSEcCtD
Dronedarone—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000147	0.00189	CcSEcCtD
Dronedarone—Rash—Repaglinide—type 2 diabetes mellitus	0.000146	0.00189	CcSEcCtD
Dronedarone—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000146	0.00188	CcSEcCtD
Dronedarone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000146	0.00188	CcSEcCtD
Dronedarone—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000146	0.00188	CcSEcCtD
Dronedarone—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000145	0.00187	CcSEcCtD
Dronedarone—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000145	0.00187	CcSEcCtD
Dronedarone—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000145	0.00186	CcSEcCtD
Dronedarone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000142	0.00183	CcSEcCtD
Dronedarone—Angiopathy—Metformin—type 2 diabetes mellitus	0.000142	0.00183	CcSEcCtD
Dronedarone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000142	0.00183	CcSEcCtD
Dronedarone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000141	0.00182	CcSEcCtD
Dronedarone—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000141	0.00182	CcSEcCtD
Dronedarone—ALB—liver—type 2 diabetes mellitus	0.000141	0.00564	CbGeAlD
Dronedarone—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000141	0.00181	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00014	0.0018	CcSEcCtD
Dronedarone—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000139	0.0018	CcSEcCtD
Dronedarone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000138	0.00178	CcSEcCtD
Dronedarone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000138	0.00178	CcSEcCtD
Dronedarone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000138	0.00178	CcSEcCtD
Dronedarone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000138	0.00178	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000138	0.00177	CcSEcCtD
Dronedarone—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000137	0.00176	CcSEcCtD
Dronedarone—Angioedema—Valsartan—type 2 diabetes mellitus	0.000137	0.00176	CcSEcCtD
Dronedarone—Erythema—Metformin—type 2 diabetes mellitus	0.000136	0.00175	CcSEcCtD
Dronedarone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000136	0.00175	CcSEcCtD
Dronedarone—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000136	0.00175	CcSEcCtD
Dronedarone—Angioedema—Orlistat—type 2 diabetes mellitus	0.000135	0.00174	CcSEcCtD
Dronedarone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000134	0.00536	CbGeAlD
Dronedarone—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000134	0.00172	CcSEcCtD
Dronedarone—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000133	0.00172	CcSEcCtD
Dronedarone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.00172	CcSEcCtD
Dronedarone—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.00171	CcSEcCtD
Dronedarone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000132	0.0017	CcSEcCtD
Dronedarone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000132	0.0017	CcSEcCtD
Dronedarone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000131	0.00169	CcSEcCtD
Dronedarone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000131	0.00525	CbGeAlD
Dronedarone—Amiodarone—CYP3A4—type 2 diabetes mellitus	0.000131	0.0756	CrCbGaD
Dronedarone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00013	0.00168	CcSEcCtD
Dronedarone—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00013	0.00168	CcSEcCtD
Dronedarone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00013	0.00168	CcSEcCtD
Dronedarone—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000129	0.00166	CcSEcCtD
Dronedarone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000129	0.00166	CcSEcCtD
Dronedarone—Erythema—Irbesartan—type 2 diabetes mellitus	0.000128	0.00165	CcSEcCtD
Dronedarone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000128	0.00165	CcSEcCtD
Dronedarone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00165	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000128	0.00164	CcSEcCtD
Dronedarone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000127	0.00163	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000126	0.00163	CcSEcCtD
Dronedarone—Angiopathy—Losartan—type 2 diabetes mellitus	0.000126	0.00162	CcSEcCtD
Dronedarone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000126	0.00162	CcSEcCtD
Dronedarone—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000126	0.00162	CcSEcCtD
Dronedarone—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000125	0.00162	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000125	0.00161	CcSEcCtD
Dronedarone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000123	0.00158	CcSEcCtD
Dronedarone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.00157	CcSEcCtD
Dronedarone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000122	0.00157	CcSEcCtD
Dronedarone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000122	0.00157	CcSEcCtD
Dronedarone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000122	0.00486	CbGeAlD
Dronedarone—Rash—Glipizide—type 2 diabetes mellitus	0.000121	0.00156	CcSEcCtD
Dronedarone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000121	0.00156	CcSEcCtD
Dronedarone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000121	0.00156	CcSEcCtD
Dronedarone—Erythema—Losartan—type 2 diabetes mellitus	0.000121	0.00156	CcSEcCtD
Dronedarone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000121	0.00155	CcSEcCtD
Dronedarone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.00154	CcSEcCtD
Dronedarone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000119	0.00153	CcSEcCtD
Dronedarone—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000118	0.00152	CcSEcCtD
Dronedarone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.00152	CcSEcCtD
Dronedarone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000117	0.00151	CcSEcCtD
Dronedarone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000117	0.00151	CcSEcCtD
Dronedarone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000117	0.00151	CcSEcCtD
Dronedarone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000117	0.00151	CcSEcCtD
Dronedarone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00149	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000115	0.00148	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000115	0.00148	CcSEcCtD
Dronedarone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000114	0.00147	CcSEcCtD
Dronedarone—Nausea—Glipizide—type 2 diabetes mellitus	0.000114	0.00147	CcSEcCtD
Dronedarone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000114	0.00147	CcSEcCtD
Dronedarone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00146	CcSEcCtD
Dronedarone—Rash—Glimepiride—type 2 diabetes mellitus	0.000113	0.00146	CcSEcCtD
Dronedarone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000113	0.00145	CcSEcCtD
Dronedarone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00145	CcSEcCtD
Dronedarone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00145	CcSEcCtD
Dronedarone—ADRA1A—liver—type 2 diabetes mellitus	0.000112	0.00448	CbGeAlD
Dronedarone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000111	0.00143	CcSEcCtD
Dronedarone—Angioedema—Losartan—type 2 diabetes mellitus	0.00011	0.00142	CcSEcCtD
Dronedarone—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000109	0.0014	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000109	0.0014	CcSEcCtD
Dronedarone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.0014	CcSEcCtD
Dronedarone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000108	0.00139	CcSEcCtD
Dronedarone—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.00139	CcSEcCtD
Dronedarone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000107	0.00138	CcSEcCtD
Dronedarone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.00138	CcSEcCtD
Dronedarone—ADRA2C—liver—type 2 diabetes mellitus	0.000107	0.00427	CbGeAlD
Dronedarone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000107	0.00137	CcSEcCtD
Dronedarone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000106	0.00425	CbGeAlD
Dronedarone—CYP3A4—kidney—type 2 diabetes mellitus	0.000106	0.00424	CbGeAlD
Dronedarone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00137	CcSEcCtD
Dronedarone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000106	0.00137	CcSEcCtD
Dronedarone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000106	0.00137	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000105	0.00136	CcSEcCtD
Dronedarone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000105	0.00135	CcSEcCtD
Dronedarone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000105	0.00135	CcSEcCtD
Dronedarone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000105	0.00135	CcSEcCtD
Dronedarone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000105	0.00135	CcSEcCtD
Dronedarone—CYP2D6—kidney—type 2 diabetes mellitus	0.000105	0.00418	CbGeAlD
Dronedarone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000104	0.00134	CcSEcCtD
Dronedarone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000104	0.00134	CcSEcCtD
Dronedarone—Erythema—Ramipril—type 2 diabetes mellitus	0.000104	0.00133	CcSEcCtD
Dronedarone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00132	CcSEcCtD
Dronedarone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.00132	CcSEcCtD
Dronedarone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00131	CcSEcCtD
Dronedarone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00131	CcSEcCtD
Dronedarone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000102	0.00131	CcSEcCtD
Dronedarone—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000102	0.00131	CcSEcCtD
Dronedarone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000101	0.0013	CcSEcCtD
Dronedarone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.98e-05	0.00128	CcSEcCtD
Dronedarone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.87e-05	0.00127	CcSEcCtD
Dronedarone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.86e-05	0.00127	CcSEcCtD
Dronedarone—Dyspepsia—Metformin—type 2 diabetes mellitus	9.78e-05	0.00126	CcSEcCtD
Dronedarone—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.68e-05	0.00125	CcSEcCtD
Dronedarone—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.64e-05	0.00124	CcSEcCtD
Dronedarone—Nausea—Bromocriptine—type 2 diabetes mellitus	9.61e-05	0.00124	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.59e-05	0.00124	CcSEcCtD
Dronedarone—Fatigue—Metformin—type 2 diabetes mellitus	9.58e-05	0.00123	CcSEcCtD
Dronedarone—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.53e-05	0.00123	CcSEcCtD
Dronedarone—Asthenia—Gliclazide—type 2 diabetes mellitus	9.53e-05	0.00123	CcSEcCtD
Dronedarone—Angioedema—Ramipril—type 2 diabetes mellitus	9.47e-05	0.00122	CcSEcCtD
Dronedarone—Vomiting—Glyburide—type 2 diabetes mellitus	9.4e-05	0.00121	CcSEcCtD
Dronedarone—Pruritus—Gliclazide—type 2 diabetes mellitus	9.39e-05	0.00121	CcSEcCtD
Dronedarone—Rash—Glyburide—type 2 diabetes mellitus	9.32e-05	0.0012	CcSEcCtD
Dronedarone—Dermatitis—Glyburide—type 2 diabetes mellitus	9.32e-05	0.0012	CcSEcCtD
Dronedarone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.00119	CcSEcCtD
Dronedarone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.09e-05	0.00117	CcSEcCtD
Dronedarone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.08e-05	0.00117	CcSEcCtD
Dronedarone—ABCB1—retina—type 2 diabetes mellitus	9.08e-05	0.00363	CbGeAlD
Dronedarone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.00117	CcSEcCtD
Dronedarone—Fatigue—Irbesartan—type 2 diabetes mellitus	9.04e-05	0.00116	CcSEcCtD
Dronedarone—Nausea—Glyburide—type 2 diabetes mellitus	8.78e-05	0.00113	CcSEcCtD
Dronedarone—Abdominal pain—Metformin—type 2 diabetes mellitus	8.78e-05	0.00113	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.76e-05	0.00113	CcSEcCtD
Dronedarone—Asthenia—Valsartan—type 2 diabetes mellitus	8.75e-05	0.00113	CcSEcCtD
Dronedarone—Dyspepsia—Losartan—type 2 diabetes mellitus	8.69e-05	0.00112	CcSEcCtD
Dronedarone—Asthenia—Orlistat—type 2 diabetes mellitus	8.65e-05	0.00111	CcSEcCtD
Dronedarone—Pruritus—Valsartan—type 2 diabetes mellitus	8.63e-05	0.00111	CcSEcCtD
Dronedarone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.0011	CcSEcCtD
Dronedarone—ABCB1—nephron tubule—type 2 diabetes mellitus	8.56e-05	0.00342	CbGeAlD
Dronedarone—Pruritus—Orlistat—type 2 diabetes mellitus	8.53e-05	0.0011	CcSEcCtD
Dronedarone—Fatigue—Losartan—type 2 diabetes mellitus	8.51e-05	0.0011	CcSEcCtD
Dronedarone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.46e-05	0.00109	CcSEcCtD
Dronedarone—Vomiting—Gliclazide—type 2 diabetes mellitus	8.44e-05	0.00109	CcSEcCtD
Dronedarone—Rash—Gliclazide—type 2 diabetes mellitus	8.37e-05	0.00108	CcSEcCtD
Dronedarone—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.36e-05	0.00108	CcSEcCtD
Dronedarone—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.35e-05	0.00107	CcSEcCtD
Dronedarone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.3e-05	0.00107	CcSEcCtD
Dronedarone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.00107	CcSEcCtD
Dronedarone—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.25e-05	0.00106	CcSEcCtD
Dronedarone—Skin disorder—Ramipril—type 2 diabetes mellitus	8.22e-05	0.00106	CcSEcCtD
Dronedarone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.07e-05	0.00104	CcSEcCtD
Dronedarone—Asthenia—Metformin—type 2 diabetes mellitus	7.97e-05	0.00103	CcSEcCtD
Dronedarone—Nausea—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.00102	CcSEcCtD
Dronedarone—Pruritus—Metformin—type 2 diabetes mellitus	7.86e-05	0.00101	CcSEcCtD
Dronedarone—Abdominal pain—Losartan—type 2 diabetes mellitus	7.8e-05	0.001	CcSEcCtD
Dronedarone—Vomiting—Valsartan—type 2 diabetes mellitus	7.76e-05	0.000999	CcSEcCtD
Dronedarone—Rash—Valsartan—type 2 diabetes mellitus	7.69e-05	0.000991	CcSEcCtD
Dronedarone—Dermatitis—Valsartan—type 2 diabetes mellitus	7.69e-05	0.00099	CcSEcCtD
Dronedarone—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.68e-05	0.00307	CbGeAlD
Dronedarone—Vomiting—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000987	CcSEcCtD
Dronedarone—Diarrhoea—Metformin—type 2 diabetes mellitus	7.6e-05	0.000979	CcSEcCtD
Dronedarone—Rash—Orlistat—type 2 diabetes mellitus	7.6e-05	0.000979	CcSEcCtD
Dronedarone—Dermatitis—Orlistat—type 2 diabetes mellitus	7.59e-05	0.000978	CcSEcCtD
Dronedarone—Asthenia—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000969	CcSEcCtD
Dronedarone—ABCB1—kidney—type 2 diabetes mellitus	7.52e-05	0.003	CbGeAlD
Dronedarone—ABCB1—pancreas—type 2 diabetes mellitus	7.47e-05	0.00298	CbGeAlD
Dronedarone—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000959	CcSEcCtD
Dronedarone—Pruritus—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000955	CcSEcCtD
Dronedarone—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.32e-05	0.00293	CbGeAlD
Dronedarone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000941	CcSEcCtD
Dronedarone—Fatigue—Ramipril—type 2 diabetes mellitus	7.29e-05	0.000939	CcSEcCtD
Dronedarone—Nausea—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000933	CcSEcCtD
Dronedarone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000924	CcSEcCtD
Dronedarone—Nausea—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000922	CcSEcCtD
Dronedarone—Asthenia—Losartan—type 2 diabetes mellitus	7.08e-05	0.000912	CcSEcCtD
Dronedarone—Vomiting—Metformin—type 2 diabetes mellitus	7.06e-05	0.00091	CcSEcCtD
Dronedarone—Rash—Metformin—type 2 diabetes mellitus	7.01e-05	0.000902	CcSEcCtD
Dronedarone—Dermatitis—Metformin—type 2 diabetes mellitus	7e-05	0.000901	CcSEcCtD
Dronedarone—Pruritus—Losartan—type 2 diabetes mellitus	6.98e-05	0.000899	CcSEcCtD
Dronedarone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000891	CcSEcCtD
Dronedarone—ABCB1—adipose tissue—type 2 diabetes mellitus	6.78e-05	0.00271	CbGeAlD
Dronedarone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.75e-05	0.000869	CcSEcCtD
Dronedarone—CYP3A4—liver—type 2 diabetes mellitus	6.71e-05	0.00268	CbGeAlD
Dronedarone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000861	CcSEcCtD
Dronedarone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.000858	CcSEcCtD
Dronedarone—Rash—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.000851	CcSEcCtD
Dronedarone—CYP2D6—liver—type 2 diabetes mellitus	6.61e-05	0.00264	CbGeAlD
Dronedarone—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.00085	CcSEcCtD
Dronedarone—Nausea—Metformin—type 2 diabetes mellitus	6.6e-05	0.00085	CcSEcCtD
Dronedarone—Vomiting—Losartan—type 2 diabetes mellitus	6.27e-05	0.000808	CcSEcCtD
Dronedarone—Nausea—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000802	CcSEcCtD
Dronedarone—Rash—Losartan—type 2 diabetes mellitus	6.22e-05	0.000801	CcSEcCtD
Dronedarone—Dermatitis—Losartan—type 2 diabetes mellitus	6.22e-05	0.0008	CcSEcCtD
Dronedarone—Asthenia—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000782	CcSEcCtD
Dronedarone—Pruritus—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000771	CcSEcCtD
Dronedarone—Nausea—Losartan—type 2 diabetes mellitus	5.86e-05	0.000755	CcSEcCtD
Dronedarone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000745	CcSEcCtD
Dronedarone—Vomiting—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000693	CcSEcCtD
Dronedarone—Rash—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000687	CcSEcCtD
Dronedarone—Dermatitis—Ramipril—type 2 diabetes mellitus	5.33e-05	0.000686	CcSEcCtD
Dronedarone—Nausea—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000647	CcSEcCtD
Dronedarone—ABCB1—liver—type 2 diabetes mellitus	4.75e-05	0.0019	CbGeAlD
Dronedarone—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.58e-07	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.57e-07	1.19e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	9.56e-07	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	9.53e-07	1.18e-05	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—AKT1—type 2 diabetes mellitus	9.48e-07	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.48e-07	1.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	9.46e-07	1.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	9.46e-07	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.46e-07	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	9.45e-07	1.18e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	9.45e-07	1.17e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.45e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	9.44e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.42e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.41e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.41e-07	1.17e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	9.41e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	9.4e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.39e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	9.38e-07	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.37e-07	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	9.34e-07	1.16e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	9.3e-07	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.29e-07	1.15e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	9.28e-07	1.15e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	9.27e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.26e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.26e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	9.25e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	9.25e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARA—type 2 diabetes mellitus	9.2e-07	1.14e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.16e-07	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.15e-07	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.14e-07	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.14e-07	1.14e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.13e-07	1.13e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	9.01e-07	1.12e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9e-07	1.12e-05	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—AKT1—type 2 diabetes mellitus	8.98e-07	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.94e-07	1.11e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	8.94e-07	1.11e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AGT—type 2 diabetes mellitus	8.91e-07	1.11e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	8.91e-07	1.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.89e-07	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.88e-07	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.8e-07	1.09e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CALM1—type 2 diabetes mellitus	8.76e-07	1.09e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.76e-07	1.09e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOE—type 2 diabetes mellitus	8.73e-07	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.73e-07	1.08e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.68e-07	1.08e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	8.67e-07	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.67e-07	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	8.67e-07	1.08e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOA1—type 2 diabetes mellitus	8.63e-07	1.07e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.6e-07	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	8.6e-07	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.59e-07	1.07e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.57e-07	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.54e-07	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.53e-07	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.53e-07	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	8.51e-07	1.06e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.42e-07	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.4e-07	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.4e-07	1.04e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	8.39e-07	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.37e-07	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	8.29e-07	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	8.29e-07	1.03e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.27e-07	1.03e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.27e-07	1.03e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.27e-07	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.25e-07	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.23e-07	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.22e-07	1.02e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.22e-07	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.19e-07	1.02e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.17e-07	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.12e-07	1.01e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.11e-07	1.01e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.07e-07	1e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.06e-07	1e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.04e-07	1e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	8.03e-07	9.98e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.03e-07	9.98e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	7.91e-07	9.83e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	7.9e-07	9.83e-06	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.9e-07	9.82e-06	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—AKT1—type 2 diabetes mellitus	7.89e-07	9.81e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.87e-07	9.79e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.87e-07	9.78e-06	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.83e-07	9.73e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.83e-07	9.73e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.81e-07	9.71e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	7.81e-07	9.71e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.78e-07	9.67e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.78e-07	9.67e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.76e-07	9.64e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.75e-07	9.63e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.71e-07	9.58e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	7.68e-07	9.54e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	7.65e-07	9.51e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.65e-07	9.5e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.64e-07	9.5e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.61e-07	9.46e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—type 2 diabetes mellitus	7.61e-07	9.46e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.6e-07	9.44e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	7.58e-07	9.42e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	7.56e-07	9.4e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.56e-07	9.4e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	7.49e-07	9.3e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.48e-07	9.29e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.48e-07	9.29e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—INS—type 2 diabetes mellitus	7.46e-07	9.27e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.46e-07	9.27e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.46e-07	9.27e-06	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	7.42e-07	9.22e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.4e-07	9.2e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.36e-07	9.15e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.33e-07	9.11e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.32e-07	9.1e-06	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.31e-07	9.09e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.29e-07	9.06e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.26e-07	9.02e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.25e-07	9.01e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.25e-07	9.01e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.24e-07	8.99e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.21e-07	8.96e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.2e-07	8.95e-06	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.2e-07	8.95e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.18e-07	8.92e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.17e-07	8.91e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.17e-07	8.91e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.13e-07	8.86e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	7.13e-07	8.86e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.11e-07	8.84e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.08e-07	8.81e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	7.02e-07	8.73e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.93e-07	8.62e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.93e-07	8.62e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.85e-07	8.51e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.82e-07	8.48e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.77e-07	8.42e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.76e-07	8.4e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.74e-07	8.38e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.69e-07	8.32e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.67e-07	8.29e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6.67e-07	8.28e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.64e-07	8.26e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.64e-07	8.25e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.58e-07	8.18e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.56e-07	8.16e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	6.54e-07	8.13e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NOS3—type 2 diabetes mellitus	6.54e-07	8.13e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.54e-07	8.13e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.54e-07	8.12e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.53e-07	8.11e-06	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.39e-07	7.95e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.33e-07	7.87e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	6.31e-07	7.85e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.29e-07	7.82e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.28e-07	7.81e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	6.21e-07	7.72e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.18e-07	7.68e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.18e-07	7.68e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.16e-07	7.66e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.15e-07	7.64e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.15e-07	7.64e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.1e-07	7.58e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.07e-07	7.54e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.05e-07	7.52e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.04e-07	7.51e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.99e-07	7.45e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.99e-07	7.44e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	5.98e-07	7.44e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.98e-07	7.43e-06	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.94e-07	7.38e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.92e-07	7.36e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.92e-07	7.36e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.89e-07	7.32e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.89e-07	7.32e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.85e-07	7.27e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.81e-07	7.22e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.73e-07	7.13e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.73e-07	7.13e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.73e-07	7.12e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.65e-07	7.02e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.64e-07	7.01e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.62e-07	6.99e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.56e-07	6.91e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.55e-07	6.9e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.53e-07	6.88e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.52e-07	6.86e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.51e-07	6.84e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.5e-07	6.84e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.49e-07	6.82e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.45e-07	6.77e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.4e-07	6.71e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.4e-07	6.71e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.39e-07	6.7e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.38e-07	6.68e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.34e-07	6.64e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.28e-07	6.56e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.24e-07	6.52e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.13e-07	6.37e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.06e-07	6.29e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	5.04e-07	6.27e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.99e-07	6.21e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.97e-07	6.18e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.94e-07	6.14e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.93e-07	6.13e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.84e-07	6.01e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.81e-07	5.98e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.73e-07	5.88e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.71e-07	5.86e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	4.69e-07	5.83e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.66e-07	5.79e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.65e-07	5.78e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.59e-07	5.71e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.58e-07	5.7e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.55e-07	5.66e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.49e-07	5.59e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	4.25e-07	5.29e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.24e-07	5.27e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.2e-07	5.22e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.19e-07	5.2e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.11e-07	5.1e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.03e-07	5.01e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.92e-07	4.88e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.86e-07	4.8e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	3.81e-07	4.74e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.72e-07	4.62e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.69e-07	4.59e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-07	4.39e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-07	4.39e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.45e-07	4.29e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.43e-07	4.26e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.23e-07	4.02e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.19e-07	3.96e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—type 2 diabetes mellitus	3.01e-07	3.74e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.64e-07	3.28e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.48e-07	3.09e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-07	2.02e-06	CbGpPWpGaD
